December 13th, 2024 (Shanghai) — We are glad to announce that Taek-Han Yoon, Business Development Manager of Aptamer Sciences, will be presenting at the ACCESS CHINA Partnering Forum @ JPM on January 7th-9th, and 21st-23rd, 2025. ACCESS CHINA Biotech Forum is the largest corporate access event between Asia and the Western biopharma industry.
About Aptamer Sciences
Aptamer Sciences, Inc. is a clinical-stage bio-firm with its platform technology, ApDC® (Aptamer Drug Conjugate), dedicated to developing innovative therapeutics that address high unmet medical needs. The ApDC® platform specifically offers effective and safe targeted anticancer therapies in a cost-effective manner. Unlike antibody-based targeted therapies, ApDC® benefits from its smaller size, enabling rapid cell internalization and superior tissue penetration. Additionally, as a nucleic acid-based modality, it provides predictable and manageable CMC during the chemical synthesis process.
The company’s leading pipeline includes AST-201, which targets GPC3 with potential indications of HCC and NSCLC under Phase 1; AST-202 and AST-203 which target CD25 and Trop2 with hematologic cancers and pancreatic cancer, respectively, under the preclinical stage. Additionally, it is developing the aptamer radioligand conjugate (ApRC®). The company is actively looking for partners who are interested in the co-development of targeted therapy using the ApDC® platform and in-licensing our assets.
About the Speaker
2022 – present: Business Development Team, Aptamer Sciences, Inc.
About ACCESS CHINA Partnering Forum
ACCESS CHINA Partnering Forum @ JPM is scheduled to be held on January 7th-9th, and 21st-23rd, 2025, via Zoom webinar. This event helps biotechs/pharmas efficiently present their assets in front of 500+ healthcare companies and VCs online. During the event, the audience can have access to innovative pharma and healthcare products from worldwide.
Conference Name: ACCESS CHINA Partnering Forum
Date & Time: January 7-9 (Live), and 21-23(VoD), 2025, China time
Content: Keynote Speeches, Panel Discussion, Company Presentations, ChemPartner-ACCESS CHINA Dinner Reception
Scale: Expected 500+ participants Online; 100 company roadshows
Participants: Pharma/Biotech senior management and BDs
View more information at https://biotochina.org/
Contact us:
To register for ACCESS CHINA online, please visit: ACCESS CHINA Biotech Forum
For more information, please contact:
Wendi Xiang
BioToChina.org 